Nature Communications · 2021 · 16 citations · 63 references
Life SciencesMolecular BiologyPharmacologyCell SignalingDrug DiscoverySignal TransductionG Protein-coupled Receptor SignalingLigand BindingLigand-receptor InteractionsReceptor-ligand InteractionsReceptor-mediated EndocytosisSmall Gtpase SignalingCancer Cell Proliferation InhibitionCell Proliferation SignalingDual-target InhibitorsG-protein-coupled ReceptorsPhosphoinositide 3-Kinase-akt SignalingPi3k-akt Signaling PathwayRas SignalingRas Signaling Pathway
Internalization and intracellular trafficking of G protein-coupled receptors (GPCRs) play pivotal roles in cell responsiveness. Dysregulation in receptor trafficking can lead to aberrant signaling and cell behavior. Here, using an endosomal BRET-based assay in a high-throughput screen with the prototypical GPCR angiotensin II type 1 receptor (AT1R), we sought to identify receptor trafficking inhibitors from a library of ~115,000 small molecules. We identified a novel dual Ras and ARF6 inhibitor, which we named Rasarfin, that blocks agonist-mediated internalization of AT1R and other GPCRs. Rasarfin also potently inhibits agonist-induced ERK1/2 signaling by GPCRs, and MAPK and Akt signaling by EGFR, as well as prevents cancer cell proliferation. In silico modeling and in vitro studies reveal a unique binding modality of Rasarfin within the SOS-binding domain of Ras. Our findings unveil a class of dual small G protein inhibitors for receptor trafficking and signaling, useful for the inhibition of oncogenic cellular responses.
63
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman, Sanna Herrgård, Daniel K. Treiber et al. · Nature Biotechnology · 2008 · 2.4K citations
β-Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3
Patricia McDonald, Chi-wing Chow, William E. Miller et al. · Science · 2000 · 813 citations
The structural basis of the activation of Ras by Sos
P. Ann Boriack‐Sjodin, S.M. Margarit, Dafna Bar‐Sagi et al. · Nature · 1998 · 801 citations